Trial intelligence / Profile preview

Phase III Randomized Study of Pemetrexed With or Without Carboplatin in Elderly Patients With Advanced Non-Squamous NSCLC

KCT0004170Phase 3Recruiting

Sponsor
Asan Medical Center
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Asan Medical Center. Started Mar 2012; status: recruiting.

02

Drugs

pemetrexed
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on KCT0004170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call